Skip to main content
. 2023 Nov 22;89(1):80. doi: 10.5334/aogh.4151

Table 3.

End-to-end Solution Framework to Help MICs Increase Access to Future Novel Vaccines.


CATEGORIES FRONT END DRIVERS OF R&D CAPABILITIES REGULATORY DRIVERS DOWNSTREAM MARKET DRIVERS

Objectives 1: Create a long-term government strategy & vision for access to vaccine innovation
2: Strengthen R&D know-how and capabilities throughout a MIC
3: Collaborate for specific infectious diseases
4: Spur vaccine R&D through investment, funding, and other incentives/mechanisms
1: Strengthen regulatory processes in and across MICs
2: Create regulatory incentives to accelerate vaccine innovation
1: Create incentives through procurement commitments
2: Leverage regional pooled models for innovation
3: Create incentives through tiered pricing
4: Support sustainable access and vaccine implementation